These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37869289)

  • 1. Effects of somatostatin analogs on uptake of radiolabeled somatostatin analogs on imaging: a systematic review and meta-analysis.
    Wang R; Guo L; Pan L; Tian R; Shen G
    Quant Imaging Med Surg; 2023 Oct; 13(10):6814-6826. PubMed ID: 37869289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Prospective Observational Study to Evaluate the Effects of Long-Acting Somatostatin Analogs on
    Gålne A; Almquist H; Almquist M; Hindorf C; Ohlsson T; Nordenström E; Sundlöv A; Trägårdh E
    J Nucl Med; 2019 Dec; 60(12):1717-1723. PubMed ID: 31000584
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Pauwels E; Cleeren F; Tshibangu T; Koole M; Serdons K; Boeckxstaens L; Dekervel J; Vandamme T; Lybaert W; den Broeck BV; Laenen A; Clement PM; Geboes K; Cutsem EV; Stroobants S; Verslype C; Bormans G; Deroose CM
    J Nucl Med; 2023 Apr; 64(4):632-638. PubMed ID: 36265911
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-Acting Somatostatin Analog Therapy Differentially Alters
    Ayati N; Lee ST; Zakavi R; Pathmaraj K; Al-Qatawna L; Poon A; Scott AM
    J Nucl Med; 2018 Feb; 59(2):223-227. PubMed ID: 28729431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Tumor Burden on Quantitative [
    Werner RA; Hänscheid H; Leal JP; Javadi MS; Higuchi T; Lodge MA; Buck AK; Pomper MG; Lapa C; Rowe SP
    Mol Imaging Biol; 2019 Aug; 21(4):790-798. PubMed ID: 30406512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Bone Metastases by
    Tian R; Xie Q; Yu F; Du C; Yao X; Zang S; Zhang C; Zhang P; Shao G; Yang Z; Wang F; Yu J
    Contrast Media Mol Imaging; 2022; 2022():1750132. PubMed ID: 36447752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective Within-Patient Assessment of the Impact of an Unlabeled Octreotide Pre-dose on the Biodistribution and Tumor Uptake of
    Lodge MA; Solnes LB; Chaudhry MA; Wahl RL
    Mol Imaging Biol; 2021 Oct; 23(5):766-774. PubMed ID: 33829361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world comparison of healthcare resource utilization and costs of [
    Cox T; O'Connell M; Leeuwenkamp O; Palimaka S; Reed N
    Curr Med Res Opin; 2022 Aug; 38(8):1305-1317. PubMed ID: 35418254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of SSTR2 Expression Assessed by
    Fonti R; Panico M; Pellegrino S; Pulcrano A; Vastarella LA; Torbati AHM; Giuliano M; Palmieri G; De Placido S; Del Vecchio S
    J Nucl Med; 2022 Oct; 63(10):1509-1514. PubMed ID: 35273092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution and first clinical results of
    Ilhan H; Lindner S; Todica A; Cyran CC; Tiling R; Auernhammer CJ; Spitzweg C; Boeck S; Unterrainer M; Gildehaus FJ; Böning G; Jurkschat K; Wängler C; Wängler B; Schirrmacher R; Bartenstein P
    Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):870-880. PubMed ID: 31492994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Influence of Long-Acting Somatostatin Analogs on 68 Ga-DOTATATE Uptake in Patients With Neuroendocrine Tumors.
    Chahid Y; Hashimi K; van de Garde EMW; Klümpen HJ; Hendrikse NH; Booij J; Verberne HJ
    Clin Nucl Med; 2023 Sep; 48(9):757-762. PubMed ID: 37486312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in biodistribution on
    Cherk MH; Kong G; Hicks RJ; Hofman MS
    Cancer Imaging; 2018 Jan; 18(1):3. PubMed ID: 29361984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of lanreotide on uptake of
    Aalbersberg EA; de Wit-van der Veen BJ; Versleijen MWJ; Saveur LJ; Valk GD; Tesselaar MET; Stokkel MPM
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):696-703. PubMed ID: 30097670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [
    Eschbach RS; Hofmann M; Späth L; Sheikh GT; Delker A; Lindner S; Jurkschat K; Wängler C; Wängler B; Schirrmacher R; Tiling R; Brendel M; Wenter V; Dekorsy FJ; Zacherl MJ; Todica A; Ilhan H; Grawe F; Cyran CC; Unterrainer M; Rübenthaler J; Knösel T; Paul T; Boeck S; Westphalen CB; Spitzweg C; Auernhammer CJ; Bartenstein P; Unterrainer LM; Beyer L
    Front Oncol; 2023; 13():992316. PubMed ID: 36793617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential for Increasing Uptake of Radiolabeled
    Pollard JH; Menda Y; Zamba KD; Madsen M; O'Dorisio MS; O'Dorisio T; Bushnell D
    Cancer Biother Radiopharm; 2021 Oct; 36(8):632-641. PubMed ID: 34252288
    [No Abstract]   [Full Text] [Related]  

  • 16. Somatostatin analogs in the treatment of neuroendocrine tumors: current and emerging aspects.
    Mazziotti G; Mosca A; Frara S; Vitale G; Giustina A
    Expert Opin Pharmacother; 2017 Nov; 18(16):1679-1689. PubMed ID: 29067877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.
    Kwekkeboom DJ; Mueller-Brand J; Paganelli G; Anthony LB; Pauwels S; Kvols LK; O'dorisio TM; Valkema R; Bodei L; Chinol M; Maecke HR; Krenning EP
    J Nucl Med; 2005 Jan; 46 Suppl 1():62S-6S. PubMed ID: 15653653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%?
    Merola E; Alonso Gordoa T; Zhang P; Al-Toubah T; Pellè E; Kolasińska-Ćwikła A; Zandee W; Laskaratos F; de Mestier L; Lamarca A; Hernando J; Cwikla J; Strosberg J; de Herder W; Caplin M; Cives M; van Leeuwaarde R
    Oncologist; 2021 Apr; 26(4):294-301. PubMed ID: 33301235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
    Virgolini I; Traub T; Novotny C; Leimer M; Füger B; Li SR; Patri P; Pangerl T; Angelberger P; Raderer M; Burggasser G; Andreae F; Kurtaran A; Dudczak R
    Curr Pharm Des; 2002; 8(20):1781-807. PubMed ID: 12171531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Patterns and Clinical Outcomes in Advanced Lung Neuroendocrine Tumors in Real-World Settings: A Multicenter Retrospective Chart Review Study.
    Dasari A; Bergsland EK; Benson AB; Cai B; Huynh L; Totev T; Shea J; Duh MS; Neary MP; Dagohoy CG; Shih BE; Maurer VE; Chan J; Kulke MH
    Oncologist; 2019 Aug; 24(8):1066-1075. PubMed ID: 30610008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.